QBRI col­lab­o­rates with Har­vard Stem Cell In­sti­tute

BioSpectrum (Asia) - - ACADEMICS NEWS -

Qatar Bio­med­i­cal Re­search In­sti­tute (QBRI), a premier re­search in­sti­tute un­der Ha­mad Bin Khal­ifa Univer­sity (HBKU), has signed a col­lab­o­ra­tive re­search and train­ing agree­ment with the Har­vard Stem Cell In­sti­tute (HSCI) in Bos­ton, USA. The five-year ini­tia­tive in­cludes technical train­ing and re­search in stem cell bi­ol­ogy, which are es­sen­tial for dis­cov­er­ing vi­able treat­ments for di­a­betes. In this new col­lab­o­ra­tion, QBRI sci­en­tists will work closely with HSCI re­searchers to ex­change knowl­edge and best prac­tice, and to ac­cel­er­ate the trans­la­tion of dis­cov­er­ies into clin­i­cal ap­pli­ca­tions. In ad­di­tion to build­ing sci­en­tific ca­pac­ity in the re­gion, the part­ner­ship will support ground-break­ing re­search in stem cell bi­ol­ogy. Clin­i­cal tri­als that arise from these en­deav­ors will be con­ducted in col­lab­o­ra­tion with QBRI’s ma­jor stake­hold­ers, in­clud­ing Qatar-based Ha­mad Med­i­cal Cor­po­ra­tion and Sidra Medicine. QBRI aims to ad­dress ma­jor health chal­lenges over the long term by sup­port­ing sci­en­tific re­search into the molec­u­lar ba­sis of var­i­ous dis­eases, and bio­med­i­cal re­search that seeks to trans­late those in­sights into solutions for di­a­betes, neu­ro­log­i­cal dis­or­ders, and cancer. The part­ner­ship with HSCI will fa­cil­i­tate progress in these ar­eas.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.